{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:14:06Z","timestamp":1787501646185,"version":"build-2736575974"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,2,28]]},"abstract":"<jats:p>\n                    This study utilized Mendelian randomization (MR) analysis to explore the causal relationship between circulating cytokines and polycystic ovary syndrome (PCOS), and to identify potential biomarkers of PCOS mechanisms. Genetic instrumental variables for cytokines were derived from 2 large-scale genome-wide association studies (GWAS) involving 8293 and 14,824 European participants. Summary statistics from a GWAS meta-analysis (10,074 PCOS cases and 103,164 controls of European ancestry) were used in the discovery phase of MR analysis. Replication analysis utilized another GWAS meta-analysis dataset (3609 cases and 229,788 controls). The primary analysis employed the inverse-variance weighted (IVW) method, with secondary methods including constrained maximum likelihood model averaging, weighted median, and weighted mode. Meta-analysis was combined with MR results, while heterogeneity and horizontal pleiotropy were assessed using leave-one-out, MR-Egger intercept test, and Mendelian Randomization Pleiotropy Residual Sum and Outlier. Sensitivity analysis confirmed the robustness of the results. Reverse MR analysis was used to explore the association of PCOS with the identified cytokines. Meta-analysis revealed that increased CCL4 (C-C motif chemokine 4) levels were associated with a higher risk of PCOS (odds ratio [OR]\u2005=\u20051.123, 95% confidence interval [CI]: 1.056\u20131.195;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001). Decreased PCOS risk was linked to CXCL11 (C-X-C motif chemokine 11, OR\u2005=\u20050.930, 95% CI: 0.890\u20130.970; IVW-false discovery rate [FDR]\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u20054.85\u2005\u00d7\u200510\n                    <jats:sup>\u22124<\/jats:sup>\n                    ) and CD6 (T-cell surface glycoprotein CD6 isoform, OR\u2005=\u20050.730, 95% CI: 0.890\u20130.970; IVW-FDR\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.008). Sensitivity analysis confirmed the robustness of the findings. MR analysis suggests a potential causal link between alterations in CCL4, CXCL11, CD6, and PCOS risk, highlighting the role of cytokines in PCOS development and progression, warranting further investigation.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000041359","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T15:01:34Z","timestamp":1740754894000},"page":"e41359","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Circulating cytokines levels and the risk of polycystic ovary syndrome: A Mendelian randomization analysis"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6375-5703","authenticated-orcid":false,"given":"Yumin","family":"Jiang","sequence":"first","affiliation":[{"name":"Graduate School, Beijing University of Chinese Traditional, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunqing","family":"Li","sequence":"additional","affiliation":[{"name":"Gynecology Department, Beijing Traditional Chinese Medicine Hospital Affiliated to Capital Medical University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Huang","sequence":"additional","affiliation":[{"name":"Gynecology Department, Beijing Traditional Chinese Medicine Hospital Affiliated to Capital Medical University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250228","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3892\/ol.2023.13754","article-title":"Risk of endometrial cancer in patients with polycystic ovarian syndrome: a meta-analysis.","volume":"25","author":"Johnson","year":"2023","journal-title":"Oncol Lett"},{"key":"R2-20250228","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.cmet.2021.01.004","article-title":"Polycystic ovary syndrome is transmitted via a transgenerational epigenetic process.","volume":"33","author":"Mimouni","year":"2021","journal-title":"Cell Metab"},{"key":"R3-20250228","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1038\/s41591-019-0666-1","article-title":"Prenatal androgen exposure and transgenerational susceptibility to polycystic ovary syndrome.","volume":"25","author":"Risal","year":"2019","journal-title":"Nat Med"},{"key":"R4-20250228","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/humupd\/dmac011","article-title":"Prevalence of PCOS and related hyperandrogenic traits in premenopausal women with type 1 diabetes: a systematic review and meta-analysis.","volume":"28","author":"Ane","year":"2022","journal-title":"Hum Reprod Update"},{"key":"R5-20250228","doi-asserted-by":"crossref","first-page":"103628","DOI":"10.1016\/j.jri.2022.103628","article-title":"Systemic and ovarian inflammation in women with polycystic ovary syndrome.","volume":"151","author":"Zhai","year":"2022","journal-title":"J Reprod Immunol"},{"key":"R6-20250228","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nm.2627","article-title":"The cellular and signaling networks linking the immune system and metabolism in disease.","volume":"18","author":"Osborn","year":"2012","journal-title":"Nat Med"},{"key":"R7-20250228","doi-asserted-by":"crossref","first-page":"40","DOI":"10.55133\/eji.300405","article-title":"Assessment of chemokines MIP-1\u03b1 and MIP-1 \u03b2in Iraqi women with polycystic ovarian syndrome.","volume":"30","author":"Alsaffar","year":"2023","journal-title":"Egyptian J Immunol"},{"key":"R8-20250228","doi-asserted-by":"crossref","first-page":"104281","DOI":"10.1016\/j.jri.2024.104281","article-title":"Comparison of serum levels of IL-10 and IL-11 and mRNA expression of IL-10, IL-11, COX-2, BCL6, and ZEB Family in peripheral blood mononuclear cells (PBMC) of women with polycystic ovary syndrome and healthy individuals.","volume":"164","author":"Nikseresht","year":"2024","journal-title":"J Reprod Immunol"},{"key":"R9-20250228","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/jog.14684","article-title":"Role of inflammatory markers in polycystic ovaries syndrome: In relation to insulin resistance.","volume":"47","author":"Alissa","year":"2021","journal-title":"J Obstet Gynaecol Res"},{"key":"R10-20250228","doi-asserted-by":"crossref","first-page":"497","DOI":"10.5603\/EP.a2020.0074","article-title":"Comparison of serum adiponectin and osteopontin levels along with metabolic risk factors between obese and lean women with and without PCOS.","volume":"71","author":"Alatas","year":"2020","journal-title":"Endokrynol Pol"},{"key":"R11-20250228","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ajhg.2016.11.007","article-title":"Genome-wide association study identifies 27 loci influencing concentrations of circulating cytokines and growth factors.","volume":"100","author":"Ahola-Olli","year":"2017","journal-title":"Am J Hum Genet"},{"key":"R12-20250228","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/oby.23060","article-title":"The role of inflammatory cytokines as intermediates in the pathway from increased adiposity to disease.","volume":"29","author":"Kalaoja","year":"2021","journal-title":"Obesity (Silver Spring)"},{"key":"R13-20250228","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41590-023-01588-w","article-title":"Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets.","volume":"24","author":"Zhao","year":"2023","journal-title":"Nat Immunol"},{"key":"R14-20250228","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12916-023-02736-7","article-title":"Associations of the circulating levels of cytokines with risk of amyotrophic lateral sclerosis: a Mendelian randomization study.","volume":"21","author":"Liu","year":"2023","journal-title":"BMC Med"},{"key":"R15-20250228","doi-asserted-by":"crossref","first-page":"e1007813","DOI":"10.1371\/journal.pgen.1007813","article-title":"Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria.","volume":"14","author":"Day","year":"2018","journal-title":"PLoS Genet"},{"key":"R16-20250228","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/humrep\/deab250","article-title":"Leveraging Northern European population history: novel low-frequency variants for polycystic ovary syndrome.","volume":"37","author":"Tyrmi","year":"2022","journal-title":"Hum Reprod"},{"key":"R17-20250228","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1093\/ije\/dyx034","article-title":"MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data.","volume":"46","author":"Yavorska","year":"2017","journal-title":"Int J Epidemiol"},{"key":"R18-20250228","doi-asserted-by":"crossref","first-page":"1324429","DOI":"10.3389\/fendo.2023.1324429","article-title":"Chronic low-grade inflammation and ovarian dysfunction in women with polycystic ovarian syndrome, endometriosis, and aging.","volume":"14","author":"Orisaka","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R19-20250228","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1016\/j.fertnstert.2011.07.1098","article-title":"Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and meta-analysis.","volume":"96","author":"Jatzko","year":"2011","journal-title":"Fertil Steril"},{"key":"R20-20250228","doi-asserted-by":"crossref","first-page":"e0148531","DOI":"10.1371\/journal.pone.0148531","article-title":"Interleukin-6 levels in women with polycystic ovary syndrome: a systematic review and meta-analysis.","volume":"11","author":"Peng","year":"2016","journal-title":"PLoS One"},{"key":"R21-20250228","doi-asserted-by":"crossref","first-page":"e0235404","DOI":"10.1371\/journal.pone.0235404","article-title":"The role of serum inflammatory cytokines and berberine in the insulin signaling pathway among women with polycystic ovary syndrome.","volume":"15","author":"Kuang","year":"2020","journal-title":"PLoS One"},{"key":"R22-20250228","doi-asserted-by":"crossref","first-page":"e0164021","DOI":"10.1371\/journal.pone.0164021","article-title":"High serum tumor necrosis factor-alpha levels in women with polycystic ovary syndrome: a meta-analysis.","volume":"11","author":"Gao","year":"2016","journal-title":"PLoS One"},{"key":"R23-20250228","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejogrb.2022.05.023","article-title":"Does alpha-1-acid glycoprotein determine for infertility in polycystic ovary syndrome?","volume":"274","author":"Durnus","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R24-20250228","doi-asserted-by":"crossref","first-page":"e13407","DOI":"10.1111\/aji.13407","article-title":"Association of circulating monocyte chemoattractant protein-1 levels with polycystic ovary syndrome: a meta-analysis.","volume":"86","author":"Wu","year":"2021","journal-title":"Am J Reprod Immunol"},{"key":"R25-20250228","doi-asserted-by":"crossref","first-page":"1076951","DOI":"10.3389\/fendo.2022.1076951","article-title":"Circulating apelin and chemerin levels in patients with polycystic ovary syndrome: a meta-analysis.","volume":"13","author":"Gao","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R26-20250228","doi-asserted-by":"crossref","first-page":"e0263658","DOI":"10.1371\/journal.pone.0263658","article-title":"Plasma Complement C1q\/tumor necrosis factor-related protein 15 concentration is associated with polycystic ovary syndrome.","volume":"17","author":"Vatannejad","year":"2022","journal-title":"PLoS One"},{"key":"R27-20250228","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.cyto.2016.12.020","article-title":"Follicular fluid cytokine composition and oocyte quality of polycystic ovary syndrome patients with metabolic syndrome undergoing in vitro fertilization.","volume":"91","author":"Niu","year":"2017","journal-title":"Cytokine"},{"key":"R28-20250228","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1055\/a-0992-9114","article-title":"Association between biomarkers of low-grade inflammation and sex hormones in women with polycystic ovary syndrome.","volume":"128","author":"Hatziagelaki","year":"2020","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"R29-20250228","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/s41594-023-01175-5","article-title":"Structural insights into the activation and inhibition of CXC chemokine receptor 3.","volume":"31","author":"Jiao","year":"2024","journal-title":"Nat Struct Mol Biol"},{"key":"R30-20250228","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-3-030-62658-7_4","article-title":"CXCL11 Signaling in the Tumor Microenvironment.","volume":"1302","author":"Gao","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"R31-20250228","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1189\/jlb.1103570","article-title":"I-TAC\/CXCL11 is a natural antagonist for CCR5.","volume":"76","author":"Petkovic","year":"2004","journal-title":"J Leukoc Biol"},{"key":"R32-20250228","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.fertnstert.2021.05.093","article-title":"Increased regulated on activation, normal T-cell expressed and secreted levels and cysteine-cysteine chemokine receptor 5 upregulation in omental adipose tissue and peripheral blood mononuclear cells are associated with testosterone level and insulin resistance in polycystic ovary syndrome.","volume":"116","author":"Juan","year":"2021","journal-title":"Fertil Steril"},{"key":"R33-20250228","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3390\/ijms23010134","article-title":"Cysteine-cysteine motif chemokine receptor 5 expression in letrozole-induced polycystic ovary syndrome mice.","volume":"23","author":"Seow","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R34-20250228","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.str.2015.05.019","article-title":"Structures of CD6 and Its Ligand CD166 give insight into their interaction.","volume":"23","author":"Chappell","year":"2015","journal-title":"Structure"},{"key":"R35-20250228","doi-asserted-by":"crossref","first-page":"E6912","DOI":"10.1073\/pnas.1704008114","article-title":"CD318 is a ligand for CD6.","volume":"114","author":"Enyindah-Asonye","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R36-20250228","doi-asserted-by":"crossref","first-page":"e20201011","DOI":"10.1084\/jem.20201011","article-title":"The T cell CD6 receptor operates a multitask signalosome with opposite functions in T cell activation.","volume":"218","author":"Mori","year":"2020","journal-title":"J Exp Med"},{"key":"R37-20250228","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12958-023-01183-6","article-title":"Intra-ovarian inflammatory states and their associations with embryo quality in normal-BMI PCOS patients undergoing IVF treatment.","volume":"22","author":"Shang","year":"2024","journal-title":"Reproduct Bio Endocrinol"},{"key":"R38-20250228","doi-asserted-by":"crossref","first-page":"731569","DOI":"10.3389\/fendo.2021.731569","article-title":"The association between genetically predicted systemic inflammatory regulators and polycystic ovary syndrome: a mendelian randomization study.","volume":"12","author":"Hanxiao","year":"2021","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000041359","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:43:40Z","timestamp":1785851020000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000041359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041359","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]}}}